Person profile
Address
Summit, New Jersey
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Outlook Therapeutics, Inc.
8 Mar 24
4
BRISTOL MYERS SQUIBB CO
5 Feb 24
4
BRISTOL MYERS SQUIBB CO
3 Jan 24
4
Outlook Therapeutics, Inc.
5 Oct 23
4
BRISTOL MYERS SQUIBB CO
3 Oct 23
4
BRISTOL MYERS SQUIBB CO
5 Jul 23
4
BRISTOL MYERS SQUIBB CO
4 Apr 23
4
Outlook Therapeutics, Inc.
31 Mar 23
4
BRISTOL MYERS SQUIBB CO
3 Feb 23
4
BRISTOL MYERS SQUIBB CO
4 Jan 23
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
7 Mar 24 | OTLK Outlook Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.41 | 94,441 | 38.72 k | 94,441 |
1 Feb 24 | BMY Bristol-Myers Squibb | Deferred Share Units Common Stock, $0.10 par value | Grant | Acquire A | No | No | 48.67 | 4,314.773 | 210.00 k | 27,341.22 |
31 Dec 23 | BMY Bristol-Myers Squibb | Deferred Share Units Common Stock, $0.10 par value | Grant | Acquire A | No | No | 51.31 | 706.49 | 36.25 k | 22,746.04 |
4 Oct 23 | OTLK Outlook Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.24 | 210,225 | 50.45 k | 210,225 |
30 Sep 23 | BMY Bristol-Myers Squibb | Deferred Share Units Common Stock, $0.10 par value | Grant | Acquire A | No | No | 58.04 | 624.569 | 36.25 k | 21,797.26 |